Jpmorgan Chase & CO Brainsway Ltd. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Brainsway Ltd. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 14,769 shares of BWAY stock, worth $143,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,769
Previous 3,548
316.26%
Holding current value
$143,850
Previous $21,000
547.62%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BWAY
# of Institutions
34Shares Held
3.28MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA900KShares$8.77 Million0.42% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny361KShares$3.52 Million0.01% of portfolio
-
Essex Investment Management CO LLC Boston, MA348KShares$3.39 Million0.6% of portfolio
-
Acadian Asset Management LLC Boston, MA295KShares$2.87 Million0.01% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA251KShares$2.45 Million0.6% of portfolio
About Brainsway Ltd.
- Ticker BWAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,519,200
- Market Cap $161M
- Description
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...